The 5 analysts offering 12-month price forecasts for ABIOMED Inc have a median target of 350.00, with a high estimate of 365.00 and a low estimate of 217.00. The median estimate represents a +38.92% increase from the last price of 251.94.
The current consensus among 9 polled investment analysts is to Buy stock in ABIOMED Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.10
Reporting Date Feb 04
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.